YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1
Clinicians can now access evidence-based clinical content live during consultations via the Corti Assistant app
SINGAPORE and TOKYO,Feb. 19,2025-- In connection with the ongoing Smart Energy Week 2025 - H2 & FC EXPO in Tokyo,Hydrexia SingaporePte Ltd.,a wholly owned company of Hydrexia Holding Limited(Hydr
Samsara enables customizable and adaptable modern driver safety training methods and solutions and helps customers improve their operations while delivering cost savings
OSAKA,Japan,Feb. 19,2025-- ANICAV – the Italian Association of Canned Vegetable Industries - is thrilled to announce a special in-store promotion at AEON Mall Dainichi,from February 27 to March 2,202
This award-winning campaign raises awareness about the climate & societal benefits of Black-led climate solutions
